Therapeutic choices in the treatment of acute community-acquired bacterial rhinosinusitis.
BACKGROUND
Acute bacterial rhinosinusitis (ABRS) is a common medical problem affecting a large percentage of the population. The disease will most often follow a viral upper respiratory tract infection.


METHODS
Appropriately diagnosed, ABRS is best treated with antibiotics, but other medications may play a role in some circumstances. Increasing antibiotic resistance to the common bacteria causing ABRS has occurred in the past 20 years, driven largely by inappropriate or unnecessary antibiotic use.


RESULTS
There are many antibiotics available that may be used for the treatment of ABRS. The selection of the best antibiotic option is determined by evaluating a number of factors, with the potential antibiotic resistance being an important consideration.


CONCLUSIONS
This article reviews current recommendations for the antibiotic treatment of ABRS.
Benninger
Michael S
MS
Department of Otolaryngology-Head and Neck Surgery, Henry Ford Hospital, 2799 West Grand Boulevard, Detroit, MI 48202, USA. mbenning@hfhs.org
D000208:Acute Disease; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017714:Community-Acquired Infections / Q000188:drug therapy*; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D012220:Rhinitis / Q000150:complications / Q000188:drug therapy*; D012852:Sinusitis / Q000150:complications / Q000188:drug therapy*; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D005938:Glucocorticoids